medscopeglobal.com · Léky · EMA
Léková novinka
Přípravek: Hexacima
Schváleno22. června 2026
Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisation: 17/04/2013, Date of refusal: 22/02/2013, Revision: 35, Status: Authorised

